Retail Pharmacy in Brazil Current Demand Behavior Analysis¶
Demand Behavior¶
The demand behavior in the Brazilian retail pharmacy industry is characterized by a significant number of both individual consumers (B2C) and business consumers (B2B), with a clear indication of overall market growth in recent years.
The primary drivers of demand in the retail pharmacy sector are the Business-to-Consumer (B2C) final customers, who are the individual end consumers across Brazil. This segment represents the vast majority of interactions at the retail level. Brazil's population, which constitutes these end consumers, was estimated to be over 212 million people. [Investe SP] Recent estimates for the Brazilian population indicate continued growth, with figures for 2025 projected to be around 218.8 million to 221.6 million, showing an increase compared to 2024 estimates. These consumers visit pharmacies to purchase a wide range of products, including prescription and over-the-counter medications, as well as non-pharmaceutical items such as hygiene, cosmetics, and convenience goods. They are also increasingly utilizing health services offered within pharmacies.
While the retail pharmacy value chain primarily focuses on the B2C segment as the final point of sale for individual consumption, there are also crucial Business-to-Business (B2B) customers within the broader pharmaceutical ecosystem. These include institutional clients such as hospitals and clinics, and the public sector through government health programs like SUS and Farmácia Popular. These B2B customers primarily interact with manufacturers and distributors within the value chain, procuring pharmaceuticals for use in healthcare facilities or public distribution. Although the provided reports detail the significant volume and value of transactions involving these B2B segments at the manufacturing and distribution levels (e.g., specialized distributors moving R$ 44 billion in the institutional market in the 12 months to March 2025), they do not provide specific numbers or direct growth/decline data for these entities as customers of retail pharmacies themselves. [Value Chain Analysis]
Evaluation of the available data strongly indicates that the number of customers served by the Brazilian retail pharmacy market is growing. This growth is evident in several key metrics for 2024:
- Increase in Sales Volume: The total volume of units sold in the retail pharmacy market in 2024 reached 8.1 billion, a significant increase from 7.6 billion units sold in 2023. [E-Commerce Brasil, InovaFarma] This 6.1% growth in volume directly reflects a higher number of purchase transactions by consumers.
- Market Value Growth: The total retail pharmacy market size grew by 11% in value, reaching R$ 158.4 billion in 2024. [E-Commerce Brasil, InovaFarma, Medicina SA] While influenced by factors like price increases, this substantial value growth alongside volume growth points to a healthy and expanding market with increasing consumer expenditure.
- Expansion of Retail Footprint: The number of pharmacies and drugstores operating in Brazil increased to 93.7 thousand by the end of 2024. [InovaFarma] Furthermore, an average of 22 new pharmacies were opened every day in Brazil in 2024. This expansion in the number of physical access points suggests that the industry is reaching a larger customer base and increasing convenience for existing customers.
- Large Chains Performance: Leading pharmacy chains, while representing a smaller percentage of the total store count, account for a significant portion of revenue and medication dispensations, and have maintained expansion projects for 2024. [Estadão RI, Giro News, Panorama Farmacêutico, Panorama Farmacêutico]
The combination of population growth, increased sales volume and value, and the physical expansion of the retail network all point towards a growing number of individual consumers engaging with the Brazilian retail pharmacy market. While specific quantification of the change in the number of unique individual customers is not provided, the substantial increase in transactional volume and access points serves as strong evidence of customer base expansion.
Table showing the growth/decline in the number of customers.¶
Based on the available data focusing on the retail pharmacy's direct interaction with customers:
| Metric | 2023 Data | 2024 Data | Growth/Decline | Indication of Customer Trend |
|---|---|---|---|---|
| Total Units Sold (Retail) | 7.6 billion | 8.1 billion | +6.1% | Growing number of customer transactions / possibly more customers |
| Total Retail Sales (Value) | R$ 142.7 billion | R$ 158.4 billion | +11% | Growing market size and consumer spending |
| Number of Retail Pharmacies | Not specified | 93.7 thousand | Increase | Increased access for customers |
| New Pharmacies Opened Daily | Not specified | 22 | Growth | Market reaching more potential customers |
| Brazilian Population | ~216.4 - 219.6 million | ~212.6 - 218.8 million | Growth | Growing base of potential B2C customers |
Note: Specific year-over-year data for the total number of individual retail customers or B2B customers of retail pharmacies was not explicitly provided in the source texts. The trends are inferred from overall market volume, value, and infrastructure growth.
References¶
Abradilan. Crescimento das grandes redes de farmácias. https://abradilan.com.br/crescimento-das-grandes-redes-de-farmacias/ Abradilan. Farmácias destacam-se entre 120 maiores varejistas do Brasil. https://abradilan.com.br/farmacias-destacam-se-entre-120-maiores-varejistas-do-brasil/ Abradilan. Brasil tem 18 indústrias farmacêutica bilionárias. https://abradilan.com.br/brasil-tem-18-industrias-farmaceutica-bilionarias/ Abradilan. Das 20 maiores farmacêuticas do Brasil, 17 são nacionais. https://abradilan.com.br/das-20-maiores-farmaceuticas-do-brasil-17-so-nacionais/ Abradilan. Dez maiores farmacêuticas do Brasil detêm 48,6% das vendas. https://abradilan.com.br/dez-maiores-farmaceuticas-do-brasil-detem-486-das-vendas/ E-Commerce Brasil. Varejo farmacêutico brasileiro soma R$ 158,4 bi em 2024. https://web.archive.org/web/20240523095902/https://ecommercebrasil.com.br/noticias/varejo-farmaceutico-brasileiro-soma-r-158-4-bi-em-2024 Estadão RI. Principais redes de farmácias faturaram R$ 91,3 bi em 2023. https://web.archive.org/web/20240509012914/https://conteudo.estadao.com.br/system/public/estadaori/2024/04/29/principais-redes-de-farmacias-faturaram-r-913-bi-em-2023.html Giro News. Redes de farmácias faturaram R$ 91,3 bilhões em 2023; RD segue no topo do ranking. https://web.archive.org/web/20240520122416/https://gironews.com/farma-cosmeticos/redes-de-farmacias-faturaram-r-913-bilhoes-em-2023-rd-segue-no-topo-do-ranking/ InovaFarma. Confira os números atualizados do mercado de varejo farmacêutico no Brasil. https://web.archive.org/web/20240523095025/https://onovovarejo.com.br/inovafarma-numeros-atualizados-mercado-varejo-farmaceutico-brasil/ Investe SP. Brasil soma 47% do mercado farmacêutico na América Latina. https://web.archive.org/web/20240517191733/https://www.investe.sp.gov.br/noticia/brasil-soma-47-do-mercado-farmaceutico-na-america-latina Novo Varejo. Conheça as 5 maiores redes de farmácia do Brasil. https://web.archive.org/web/20240523100517/https://onovovarejo.com.br/5-maiores-redes-de-farmacia-brasil/ Panorama Farmacêutico. Ranking das grandes redes de farmácias da Abrafarma. https://web.archive.org/web/20240523094400/https://panoramafarmaceutico.com.br/ranking-grandes-redes-farmacias-abrafarma-2024/ Panorama Farmacêutico. Redes de farmácias mantêm projetos de expansão para 2024. https://web.archive.org/web/20240523095253/https://panoramafarmaceutico.com.br/redes-de-farmacias-mantem-projetos-de-expansao-para-2024/ Panorama Farmacêutico. Ranking das redes de farmácias mostra consolidação do setor. https://web.archive.org/web/20240523095536/https://panoramafarmaceutico.com.br/ranking-redes-de-farmacias-mostra-consolidação-do-setor/ Pague Menos tem receita bruta de R$3,1 bi no 1T24. https://web.archive.org/web/20240523100844/https://agenciabrasil.ebc.com.br/economia/noticia/2024-05/pague-menos-tem-receita-bruta-de-r31-bi-no-1t24